Mepolizumab in patients with lymphoid variant hypereosinophilic syndrome: a multi-center prospective study đź”— Access full article via Journal of Allergy and Clinical ImmunologyShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
